IVBT (Innovation1 Biotech) Total Equity: $-3.34 Mil (As of Feb. 2024)


IVBT Innovation1 Biotech Inc IVBT
12 GF Score
Price $0.00
View Full Analysis

What is Innovation1 Biotech Total Equity?

Innovation1 Biotech IVBT 12 Total Equity is $-3.34 Mil as of Feb. 2024. GuruFocus rates IVBT with a GF Score™ of 12/100.

Innovation1 Biotech's total equity for the quarter that ended in Feb. 2024 was $-3.34 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Innovation1 Biotech Total Equity Historical Data

* Premium members only.

The historical data trend for Innovation1 Biotech's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation1 Biotech Total Equity Chart

Innovation1 Biotech Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Total Equity
Get a 7-Day Free Trial Premium Member Only 0.03 -2.68 -0.23 2.85 -3.43

Innovation1 Biotech Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.48 1.25 -3.43 -3.05 -3.34
IVBT
12GF Score
Innovation1 Biotech Inc IVBT
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innovation1 Biotech Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Innovation1 Biotech's Total Equity for the fiscal year that ended in Aug. 2023 is calculated as

Total Equity=Total Assets(Q: Aug. 2023 )-Total Liabilities(Q: Aug. 2023 )
=0.076-3.506
=-3.43

Innovation1 Biotech's Total Equity for the quarter that ended in Feb. 2024 is calculated as

Total Equity=Total Assets(Q: Feb. 2024 )-Total Liabilities(Q: Feb. 2024 )
=0.122-3.459
=-3.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-3.34 Mil mean?
Innovation1 Biotech (IVBT) has a Total Equity of $-3.34 Mil as of Feb. 2024. The total amount of equity as record on a company's balance sheet. View historical data for Innovation1 Biotech and its competitors.
Is Innovation1 Biotech's Total Equity too high?
Innovation1 Biotech's current Total Equity is $-3.34 Mil. Overall, Innovation1 Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Innovation1 Biotech's Total Equity compare to NVIV and PXMD?
Innovation1 Biotech's Total Equity of $-3.34 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Diversified Financial Services company?
A good Total Equity depends on the Diversified Financial Services industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Innovation1 Biotech and its competitors. Innovation1 Biotech's current Total Equity is $-3.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovation1 Biotech stock overvalued right now?
Innovation1 Biotech (IVBT) has a current Total Equity of $-3.34 Mil. The current Total Equity is $-3.34 Mil. Innovation1 Biotech's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Innovation1 Biotech (IVBT), the current Total Equity is $-3.34 Mil as of Feb. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovation1 Biotech Business Description

Address 7 Grand View Avenue, Somerville, MA, USA, 02143
Innovation1 Biotech Inc is a shell company.
12GF Score

Get the complete analysis for IVBT

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price